Roche Holding Aktiengesellschaft - ADR operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft - ADR with three other
companies in this sector in the United States:
sales of $52.82 billion
of which 55%
was Operating Segment-Global Innovative Phar),
Merck & Co. , Inc.
of which 88%
was Merck Pharmaceutical), and
of which 66%
was innovative medicines).
Roche Holding Aktiengesellschaft - ADR reported sales of $51.16 billion
December of 2016.
increase of 2.4%
versus 2015, when the company's sales were $49.93 billion.
Despite this increase, sales are still
below the level achieved in 2014, when Roche Holding Aktiengesellschaft - ADR
reported sales of $51.68 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Roche Holding Aktiengesellschaft - ADR had sales
of $48.40 billion.
Sales of Diagnostics saw an increase
3.5% in 2016, from
$11.22 billion to $11.60 billion.